T cell inhibitors function by targeting specific molecules involved in T cell activation and proliferation. These molecules can include surface receptors, signaling pathways, and cytokines. By inhibiting these targets, the drugs can reduce the immune response, thereby providing therapeutic benefits in conditions where the immune system is overactive.